Gene · 7399
Papers2,630
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 2,630
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multidimensional difference analysis in gastric cancer patients between high and low latitude. | Front Genet | 2022 | 35957688 | PubTator, text mining | PubMed |
| Aggregated Genomic Data as Cohort-Specific Allelic Frequencies can Boost Variants and Genes Prioritization in Non-Solved Cases of Inherited Retinal Dystrophies. | Int J Mol Sci | 2022 | 35955564 | PubTator, text mining | PubMed |
A Novel Immune-Related Gene Signature to Identify the Tumor Microenvironment and Prognose Disease Among Patients With Oral Squamous Cell Carcinoma Patients Using ssGSEA: A Bioinformatics and Biological Validation Study. | Front Immunol | 2022 | 35935989 | PubTator, text mining | PubMed |
| Comparative Analysis of Mutation Status and Immune Landscape for Squamous Cell Carcinomas at Different Anatomical sites. | Front Immunol | 2022 | 35935970 | PubTator, text mining | PubMed |
| Anatomical characteristics and potential gene mutation sites of a familial recurrent patellar dislocation. | BMC Med Genomics | 2022 | 35934709 | PubTator, text mining | PubMed |
| Advancing precision medicines for ocular disorders: Diagnostic genomics to tailored therapies. | Front Med (Lausanne) | 2022 | 35911417 | PubTator, text mining | PubMed |
| Ancient herpes simplex 1 genomes reveal recent viral structure in Eurasia. | Sci Adv | 2022 | 35895820 | PubTator, text mining | PubMed |
| Unilateral Retinitis Pigmentosa Associated with Possible Ciliopathy and a Novel Mutation. | Clin Pract | 2022 | 35892439 | PubTator, text mining | PubMed |
| A Comprehensive Evaluation of the Performance of Prediction Algorithms on Clinically Relevant Missense Variants. | Int J Mol Sci | 2022 | 35887294 | PubTator, text mining | PubMed |
| Mutational Signature and Integrative Genomic Analysis of Human Papillomavirus-Associated Penile Squamous Cell Carcinomas from Latin American Patients. | Cancers (Basel) | 2022 | 35884575 | PubTator, text mining | PubMed |
| Genomic Landscape, Clinical Features and Outcomes of Non-Small Cell Lung Cancer Patients Harboring BRAF Alterations of Distinct Functional Classes. | Cancers (Basel) | 2022 | 35884534 | PubTator, text mining | PubMed |
| Unravelling genetic variants of a swedish family with high risk of prostate cancer. | Hered Cancer Clin Pract | 2022 | 35870994 | PubTator, text mining | PubMed |
| Novel mutations of the USH2A gene cause Usher syndrome in five Chinese families. | BMC Ophthalmol | 2022 | 35870892 | PubTator, text mining | PubMed |
Performance of Deep Learning Models in Automatic Measurement of Ellipsoid Zone Area on Baseline Optical Coherence Tomography (OCT) Images From the Rate of Progression of USH2A-Related Retinal Degeneration (RUSH2A) Study. | Front Med (Lausanne) | 2022 | 35865175 | PubTator, text mining | PubMed |
| The Cellular and Molecular Landscape of Synchronous Pediatric Sialoblastoma and Hepatoblastoma. | Front Oncol | 2022 | 35860547 | PubTator, text mining | PubMed |
| Identification of Ferroptosis-Associated Genes in Prostate Cancer by Bioinformatics Analysis. | Front Genet | 2022 | 35860472 | PubTator, text mining | PubMed |
| HUMAN CELLULAR MODELS FOR RETINAL DISEASE: From Induced Pluripotent Stem Cells to Organoids. | Retina | 2022 | 35858274 | PubTator, text mining | PubMed |
| Impaired Chromatin Remodeling Predicts Better Survival to Modified Gemcitabine and S-1 plus Nivolumab in Advanced Biliary Tract Cancer: A Phase II T1219 Study. | Clin Cancer Res | 2022 | 35849151 | PubTator, text mining | PubMed |
| Music Aptitude, Training, and Cognitive Transfer: A Mini-Review. | Front Psychol | 2022 | 35846628 | PubTator, text mining | PubMed |
| SCG2: A Prognostic Marker That Pinpoints Chemotherapy and Immunotherapy in Colorectal Cancer. | Front Immunol | 2022 | 35844556 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7399/papers?page=32